TOWA PHARMACEUTICAL CO., LTD. Toevoegen aan een lijst
|
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 2.788 JPY | -0,64% |
|
-1,73% | +18,54% |
Totale waarde
| Fiscaal tijdperk: Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 143.346 | 111.557 | 120.231 | 135.736 | 93.275 | 138.109 | - | - |
| Bedrijfswaarde 1 | 178.664 | 175.237 | 179.706 | 247.034 | 242.083 | 300.641 | 299.803 | 295.075 |
| K/w-verhouding | 10,6 x | 7,69 x | 8,61 x | 8,5 x | 42,4 x | 10,9 x | 11,8 x | 10,7 x |
| Dividendrendement | 1,23% | 1,94% | 1,8% | 2,18% | 3,17% | 2,14% | 2,15% | 2,17% |
| Marktkapitalisatie/omzet | 1,36 x | 1,01 x | 0,78 x | 0,82 x | 0,45 x | 0,6 x | 0,56 x | 0,53 x |
| Bedrijfswaarde/omzet | 1,7 x | 1,59 x | 1,16 x | 1,49 x | 1,16 x | 1,31 x | 1,22 x | 1,13 x |
| Bedrijfswaarde/EBITDA | 7,35 x | 7,17 x | 6,07 x | 8,19 x | 9,71 x | 8,85 x | 8,21 x | 7,71 x |
| Bedrijfswaarde/FCF | 22,1 x | -8,6 x | 61,8 x | -6,57 x | -8,73 x | -18 x | -71,3 x | 30,5 x |
| FCF Yield | 4,53% | -11,6% | 1,62% | -15,2% | -11,5% | -5,56% | -1,4% | 3,28% |
| Price to Book | 1,56 x | 1,07 x | 1,03 x | 1,02 x | 0,68 x | 0,94 x | 0,88 x | 0,83 x |
| Aantal aandelen (in duizenden) | 49.209 | 49.209 | 49.215 | 49.394 | 49.222 | 49.219 | - | - |
| Referentieprijs 2 | 2.913 | 2.267 | 2.443 | 2.748 | 1.895 | 2.806 | 2.806 | 2.806 |
| Datum van publicatie | 14-05-19 | 14-05-20 | 14-05-21 | 13-05-22 | 15-05-23 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 105.104 | 110.384 | 154.900 | 165.615 | 208.859 | 229.894 | 245.836 | 261.816 |
| EBITDA 1 | 24.308 | 24.428 | 29.597 | 30.159 | 24.923 | 33.967 | 36.500 | 38.250 |
| Bedrijfsresultaat (EBIT) 1 | 15.968 | 16.143 | 19.923 | 19.205 | 5.514 | 15.794 | 17.888 | 19.850 |
| Operationele Marge | 15,19% | 14,62% | 12,86% | 11,6% | 2,64% | 6,87% | 7,28% | 7,58% |
| Resultaat voor belastingen (EBT) 1 | 18.886 | 20.709 | 18.728 | 22.246 | 4.605 | 19.662 | 18.235 | 20.295 |
| Nettowinst (verlies) 1 | 13.475 | 14.503 | 13.958 | 15.914 | 2.201 | 12.715 | 11.658 | 12.903 |
| Nettomarge | 12,82% | 13,14% | 9,01% | 9,61% | 1,05% | 5,53% | 4,74% | 4,93% |
| WPA 2 | 273,8 | 294,7 | 283,6 | 323,4 | 44,72 | 258,3 | 236,8 | 262,1 |
| Free Cash Flow 1 | 8.087 | -20.377 | 2.908 | -37.600 | -27.740 | -16.716 | -4.205 | 9.671 |
| FCF-marge | 7,69% | -18,46% | 1,88% | -22,7% | -13,28% | -7,27% | -1,71% | 3,69% |
| Kasstroomconversie (ebitda) | 33,27% | - | 9,83% | - | - | - | - | 25,28% |
| Kasstroomconversie (nettowinst) | 60,01% | - | 20,83% | - | - | - | - | 74,95% |
| Dividend per aandeel 2 | 35,83 | 44,00 | 44,00 | 60,00 | 60,00 | 60,00 | 60,40 | 61,00 |
| Datum van publicatie | 14-05-19 | 14-05-20 | 14-05-21 | 13-05-22 | 15-05-23 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: Maart | 2020 S1 | 2021 S1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 55.350 | 74.640 | 39.327 | 82.254 | 43.359 | 40.002 | 45.372 | 45.128 | 90.500 | 49.905 | 68.454 | 54.548 | 52.848 | 107.396 | 60.929 | 61.606 | 56.900 | 55.700 | 63.200 | 65.200 |
| EBITDA 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.894 | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | 9.218 | 8.782 | 4.231 | 10.312 | 6.681 | 2.212 | 1.940 | 1.280 | 3.220 | 2.132 | 162 | 4.096 | 2.907 | 7.003 | 6.201 | 2.496 | 3.998 | 3.348 | 6.084 | 3.470 |
| Operationele Marge | 16,65% | 11,77% | 10,76% | 12,54% | 15,41% | 5,53% | 4,28% | 2,84% | 3,56% | 4,27% | 0,24% | 7,51% | 5,5% | 6,52% | 10,18% | 4,05% | 7,03% | 6,01% | 9,63% | 5,32% |
| Resultaat voor belastingen (EBT) 1 | 9.738 | 8.655 | 5.329 | 13.043 | 8.080 | - | 2.572 | 2.008 | 4.580 | -413 | - | 7.140 | 3.252 | 10.392 | 6.898 | 2.609 | 3.898 | 3.248 | 5.984 | 3.770 |
| Nettowinst (verlies) 1 | 7.066 | 6.251 | 3.931 | 9.242 | 5.758 | 914 | 1.395 | 1.297 | 2.692 | -708 | 217 | 4.750 | 2.203 | 6.953 | 4.565 | 1.046 | 2.698 | 2.248 | 4.184 | 2.670 |
| Nettomarge | 12,77% | 8,37% | 10% | 11,24% | 13,28% | 2,28% | 3,07% | 2,87% | 2,97% | -1,42% | 0,32% | 8,71% | 4,17% | 6,47% | 7,49% | 1,7% | 4,74% | 4,04% | 6,62% | 4,1% |
| WPA 2 | 143,6 | 127,0 | 79,87 | 187,8 | 117,0 | - | 28,34 | 26,36 | 54,70 | -14,38 | - | 96,51 | 44,75 | 141,3 | 92,77 | -14,71 | - | - | - | - |
| Dividend per aandeel 2 | 22,00 | 22,00 | - | 27,00 | - | - | - | - | 30,00 | - | - | - | 30,00 | 30,00 | - | 30,00 | - | 30,00 | - | 30,00 |
| Datum van publicatie | 11-11-19 | 13-11-20 | 12-11-21 | 12-11-21 | 14-02-22 | 13-05-22 | 10-08-22 | 14-11-22 | 14-11-22 | 13-02-23 | 15-05-23 | 10-08-23 | 13-11-23 | 13-11-23 | 13-02-24 | - | - | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Balans
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | 35.318 | 63.680 | 59.475 | 111.298 | 148.808 | 162.531 | 161.694 | 156.966 |
| Nettokaspositie 1 | - | - | - | - | - | - | - | - |
| Hefboom (schuld/ebitda) | 1,453 x | 2,607 x | 2,009 x | 3,69 x | 5,971 x | 4,785 x | 4,43 x | 4,104 x |
| Free Cash Flow 1 | 8.087 | -20.377 | 2.908 | -37.600 | -27.740 | -16.716 | -4.205 | 9.671 |
| ROE (netto-inkomsten/eigen vermogen) | 15,7% | 14,8% | 12,6% | 12,8% | 1,6% | 8,94% | 7,67% | 7,99% |
| ROA (netto-inkomsten/totale activa) | 10,3% | 10,1% | 7,88% | 7,9% | 1,47% | 4,1% | 3,8% | 4,35% |
| Totale activa 1 | 130.760 | 144.042 | 177.046 | 201.419 | 150.119 | 310.113 | 306.784 | 296.623 |
| Nettoactief per aandeel 2 | 1.865 | 2.126 | 2.369 | 2.685 | 2.781 | 2.997 | 3.180 | 3.389 |
| Cashflow per aandeel | 443,0 | 463,0 | 480,0 | 530,0 | 334,0 | - | - | - |
| Capex 1 | 11.143 | 4.549 | 9.137 | 14.848 | 39.645 | 38.500 | 20.925 | 16.825 |
| Capex/omzet | 10,6% | 4,12% | 5,9% | 8,97% | 18,98% | 16,75% | 8,51% | 6,43% |
| Datum van publicatie | 14-05-19 | 14-05-20 | 14-05-21 | 13-05-22 | 15-05-23 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
5
Laatste slotkoers
2.806
JPY
Gemiddelde koersdoel
3.690
JPY
Spread / Gemiddelde doel
+31,50%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +18,54% | 903 mln. | |
| +31,52% | 662 mld. | |
| +21,96% | 546 mld. | |
| -5,21% | 359 mld. | |
| +17,02% | 323 mld. | |
| +5,01% | 289 mld. | |
| +13,68% | 234 mld. | |
| +3,81% | 198 mld. | |
| -10,63% | 194 mld. | |
| +3,98% | 167 mld. |
- Beurs
- Aandelen
- Koers 4553
- Financiën Towa Pharmaceutical Co., Ltd.
